Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 11.70 is 52% below its 5-year average of 24.17, near the low end of its 5-year range (11.70–52.06).
As of the fiscal period ended Tuesday, June 30, 2026. 5.80% below its 12-month average of 12.42.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 11.70.
CURRENT RATIO
11.70
CURRENT RATIO AVG TTM
12.42
CURRENT RATIO AVG 3Y
18.68
CURRENT RATIO AVG 5Y
24.17
CURRENT RATIO AVG 10Y
13.46
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-5.80%
CURRENT VS 3Y AVG
-37.36%
CURRENT VS 5Y AVG
-51.58%
CURRENT VS 10Y AVG
-13.07%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.58
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
+226.88%
vs the sector median at left
enVVeno Medical Corporation
Market Cap
$5.60M
Current Ratio
11.70
TTM Avg
12.42
3Y Avg
18.68
5Y Avg
24.17
Market Cap
$5.63M
Current Ratio
3.88
TTM Avg
2.19
3Y Avg
2.86
5Y Avg
5.66
Market Cap
$5.77M
Current Ratio
2.35
TTM Avg
1.31
3Y Avg
0.84
5Y Avg
0.78
Market Cap
$5.91M
Current Ratio
119.39
TTM Avg
100.04
3Y Avg
53.39
5Y Avg
40.10
Market Cap
$5.27M
Current Ratio
1.44
TTM Avg
1.10
3Y Avg
1.11
5Y Avg
1.95
Market Cap
$5.25M
Current Ratio
0.09
TTM Avg
0.18
3Y Avg
0.44
5Y Avg
0.97
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| enVVeno Medical Corporation (NVNO) | $5.60M | 11.70 | 12.42 | 18.68 | 24.17 |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.63M | 3.88 | 2.19 | 2.86 | 5.66 |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $5.77M | 2.35 | 1.31 | 0.84 | 0.78 |
| Lucyd, Inc (LUCY)vs › | $5.80M | 12.06 | 10.77 | 9.40 | 6.47 |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $5.91M | 119.39 | 100.04 | 53.39 | 40.10 |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.27M | 1.44 | 1.10 | 1.11 | 1.95 |
| Gelteq Limited Ordinary Shares (GELS)vs › | $5.25M | 0.09 | 0.18 | 0.44 | 0.97 |
| Pulmatrix, Inc. (PULM)vs › | $5.24M | 4.70 | 11.62 | 9.04 | 8.74 |
| Lunai Bioworks Inc. (LNAI)vs › | $5.21M | 0.19 | 0.06 | 0.46 | 2.58 |
| Alzamend Neuro Inc (ALZN)vs › | $5.21M | 3.01 | 3.95 | 2.52 | 4.28 |
Current Ratio
11.70
Quick Ratio
11.70
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 11.70 |
| 2026-03-31 | 11.89 |
| 2025-12-31 | 13.58 |
| 2025-09-30 | 13.12 |
| 2025-06-30 | 11.81 |
| 2025-03-31 | 23.77 |
| 2024-12-31 | 20.88 |
| 2024-09-30 | 22.01 |
| 2024-06-30 | 23.33 |
| 2024-03-31 | 29.08 |
| 2023-12-31 | 34.23 |
| 2023-09-30 | 12.91 |
| 2023-06-30 | 14.57 |
| 2023-03-31 | 29.58 |
| 2022-12-31 | 25.78 |
| 2022-09-30 | 31.22 |
| 2022-06-30 | 20.79 |
| 2022-03-31 | 40.67 |
| 2021-12-31 | 34.83 |
| 2021-09-30 | 52.06 |
| 2021-06-30 | 29.74 |
| 2021-03-31 | 23.57 |
| 2020-12-31 | 3.00 |
| 2020-09-30 | 3.12 |
| 2020-06-30 | 0.60 |
| 2020-03-31 | 0.37 |
| 2019-12-31 | 0.76 |
| 2019-09-30 | 1.52 |
| 2019-06-30 | 2.46 |
| 2019-03-31 | 1.60 |
| 2018-12-31 | 1.86 |
| 2018-09-30 | 2.30 |
| 2018-06-30 | 2.35 |
| 2018-03-31 | 0.03 |
| 2017-12-31 | 0.02 |
| 2017-09-30 | 0.10 |
| 2017-06-30 | 0.11 |
| 2017-03-31 | 0.00 |
| 2016-12-31 | 0.19 |
| 2016-09-30 | 0.38 |
| 2016-06-30 | 0.00 |
| 2016-03-31 | 0.00 |
| 2015-12-31 | 0.38 |
